Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05376241 · ClinicalTrials.gov registry record · Phase 2
Promoting Informed Choice for Breast Cancer Screening
A Phase 2 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 637
- Enrollment target
NCT05376241 is a Phase 2 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 637 participants.
The verdict
NCT05376241, a Phase 2 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 637 participants
- Enrollment target
Study Summary
Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.
Interventions
- BEHAVIORAL Decision aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 637 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2022-05-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05376241
The ClinicalTrials.gov registry entry for NCT05376241 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 637 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Decision aid is the first listed.
NCT05376241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05376241 about?
NCT05376241 is a clinical study titled "Promoting Informed Choice for Breast Cancer Screening". Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.
What is the current status of trial NCT05376241?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 637 participants. The study started on 2022-01-03. Estimated completion is 2022-05-07.
What interventions are being tested in trial NCT05376241?
The interventions under investigation include: Decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT05376241?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.